- Release Date: 05/03/21 08:32
- Summary: 2RT Post LEAD Review Shows Improved Treatment Benefits
- Price Sensitive: Yes
- Download Document 553.77KB
Ann: 2RT Post LEAD Review Shows Improved Treatment Benefits
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.8¢ |
Change
-0.003(0.93%) |
Mkt cap ! $62.92M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.5¢ | 26.5¢ | $144.8K | 536.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 237618 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 110292 | 4 |
View Market Depth
| Last trade - 12.12pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
26.5¢ |
Change
-0.003 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 27.0¢ | 27.5¢ | 26.5¢ | 199960 | ||
| Last updated 12.21pm 27/05/2024 ? | |||||
| EYE (ASX) Chart |